Here's the link to apply for CPE credit

https://www.lecturepanda.com/embed/lecture?lectkey=ag1zfnJ4Y2V0cmFja2VycicLEgZDRVVzZXIYgICArNbxmwoMCxIHTGVjdHVyZRiAgICAnJGaCgw

Use must be an NSP member

Have a need for CPE credit

Complete the survey by December 19th.

-----------------------------------------------------------------------------------------------------------

The North Suburban Pharmacists of Chicagoland Presents

A New Class of Drugs for Migraine Prevention: Calcitonin Gene-Related Peptide-Directed Treatments. Program 171

Wednesday, November 28, 2018.
Time: 6:00pm to 8:30pm
NEW Location: Moretti’s Ristorante, 6415 Dempster St, Morton Grove, IL 60053

Schedule of Events:
6:00 p.m. to 7:00 p.m.  Registration/Networking/Dinner

7:00 p.m.-8:30 p.m.: Featured CE Program Presentation.

Non-member registration is limited. Reservations are required for attendance

Please RSVP via web at www.nspharmacists.org by November 21, 2018, 6PM

Midwestern College of Pharmacy Students (non-member) MUST register with Dr. Sue Cornell at scorne@midwestern.edu . Space is limited

Rosalind Franklin College of Pharmacy Students (non-member)  MUST register with Janeen Winnike at janeen.winnike@rosalindfranklin.edu . Space is limited

Roosevelt University College of Pharmacy Students (non-member) MUST register with Joan Hardman at jhardman02@roosevelt.edu . Space is limited

University of Illinois College of Pharmacy Students (non-member) MUST register with Deb Fox at dfox4@uic.edu  . Space is limited

A New Class of Drugs for Migraine Prevention: Calcitonin Gene-Related Peptide-Directed Treatments. Program 171

Program Description

Migraine is a chronic condition characterized by episodic attacks of disabling headaches. These attacks often present with any combination of pain, nausea, light and sound sensitivity, or vomiting. In the United States, approximately 18% of women and 6% of men experience at least 1 migraine headache per year.  The total costs of disability attributable to these migraines were estimated to exceed $13 billion a year in the United States in 1998. In addition, another study found that the total cost of lost productive time due to any type of headache pain was $19.6 billion (in 2002 US dollars).

We will discuss migraine treatments with an emphasis on a new class of migraine medications.

Program Objectives

At the conclusion of this program, the pharmacist will be able to:

• 1.     Explain the mechanism of action of calcitonin gene-related peptide (CGRP)-directed treatments for migraine.
• 2.    Discuss published safety and efficacy data for approved CGRP monoclonal antibodies.
• 3.    Describe the current place in therapy of the anti-CGRP medications.
• 4.    Explain the role of the pharmacist in educating patients on the use of the CGRP products.

Technician Objectives:

At the conclusion of this program, the technician will be able to:

• 1.    Explain the mechanism of action of calcitonin gene-related peptide (CGRP)-directed treatments for migraine.
• 2.    Discuss published safety and efficacy data for approved CGRP monoclonal antibodies.
• 3.    Describe the current place in therapy of the anti-CGRP medications.
• 4.    Explain the role of the technician in the use of the CGRP products.

TARGET AUDIENCE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

This activity has been designed to meet the educational needs of pharmacists and pharmacy technicians.

SPEAKER

                                 Marlowe Djuric Kachlic, PharmD
                        Clinical Assistant Professor/Clinical Pharmacist
                        Director, PGY1 Community Residency Program
                        University of Illinois at Chicago

                        Samantha Otto-Meyer, PharmD
                        Clinical Instructor
                        Resident, PGY1 Community
                        University of Illinois at Chicago

Disclosure: Our speakers declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program.

In compliance with regulatory and continuing education guidelines/codes of ethics, guests who are not healthcare professionals are not permitted to attend.

CONTINUING EDUCATION CREDIT INFORMATION: The Illinois Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.

Funding for this program is provided by: North Suburban Pharmacists of Chicagoland 

In order to receive ACPE credit for this program, the participant must 1) Attend the program in its entirety; 2) Provide current information on the Attendance Log Form; and 3) Complete an Evaluation Form. The program’s administrator should provide attendees a Record of Attendance Form for their files. All Statements of Credit for ACPE approved – IPhA co-sponsored continuing education that individuals have completed during the year are available online at www.ipha.org.  If you do not have web access and would like a CE transcript mailed to you, please contact IPhA at (217) 522-7300 or ipha@ipha.org.

Current members: There are no fees for this program. Non-members: $50

Please RSVP via web at www.nspharmacists.org by November 21, 2018, 6PM

©2018 North Suburban Pharmacists of Chicagoland Association. All Rights Reserved